← Open Payments lookup

LAN QUACH: Open Payments

NPI 1730462904 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,303 in 100 payments from 12 companies in 2025. Trend: 2023 $4,599 · 2024 $3,509 · 2025 $4,303

Food & beverage: $4,188Consulting: $115
CompanyPaymentsAmount
Axsome Therapeutics, Inc.13$649
Neurocrine BioSciences, Inc.9$621
Janssen Pharmaceuticals, Inc7$558
Otsuka America Pharmaceutical, Inc.9$491
Lundbeck LLC19$460
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$386
Alkermes, Inc.12$381
Vanda Pharmaceuticals Inc.3$264
Takeda Pharmaceuticals U.S.A., Inc.6$152
E.R. Squibb & Sons, L.L.C.1$121

Products named: REXULTI, Auvelity, INGREZZA, CAPLYTA, INVEGA SUSTENNA, FANAPT, LYBALVI, SPRAVATO.

Industry payments across CA — which companies pay providers there.